Skip to main content
Heranba Industries Limited logo

Heranba Industries Limited — Investor Relations & Filings

Ticker · HERANBA ISIN · INE694N01015 LEI · 335800OPXIEPYCNRWS37 BSE.NS Manufacturing
Open in API
Filings indexed 442 across all filing types
Latest filing 2023-11-08 M&A Activity
Country IN India
Listing BSE.NS HERANBA

About Heranba Industries Limited

https://www.heranba.co.in/

Heranba Industries Limited specializes in the manufacturing and marketing of synthetic pyrethroids and their intermediates. The company operates an integrated business model spanning the production of technicals, formulations, and branded products. Its extensive portfolio includes key active ingredients such as Cypermethrin, Deltamethrin, Alpha Cypermethrin, and Permethrin, catering to agriculture, public health, and animal health sectors. With multiple manufacturing facilities and dedicated R&D capabilities, the company provides a wide range of insecticides, herbicides, and fungicides. Heranba maintains a global footprint, supplying products to over sixty countries while ensuring quality control from intermediate stages to final crop protection solutions.

Recent filings

Filing Released Lang Actions
Outcome of Board Meeting
M&A Activity Classification · 95% confidence The document is a formal announcement addressed to stock exchanges regarding a Share Purchase Agreement and an Open Offer for acquiring shares of Daikaffil Chemicals India Limited by Mikusu India Private Limited, a subsidiary of Heranba Industries Limited. It references compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations and SEBI (Substantial Acquisition of Shares and Takeovers) Regulations. The content details the acquisition terms, shareholding percentages, consideration, and regulatory compliance disclosures. This is a clear disclosure of a significant acquisition transaction and related open offer, which fits the category of M&A Activity announcements. The document is not a full merger proxy statement or tender offer filing but an announcement of the acquisition agreement and open offer under SEBI regulations, which aligns with the M&A Activity (TAR) category. The document length (8134 characters) and detailed content confirm it is not a brief notice or a report publication announcement. Therefore, the classification is M&A Activity (TAR) with high confidence.
2023-11-08 English
Trading Window
Regulatory Filings Classification · 95% confidence The document is a formal notification addressed to stock exchanges regarding the closure of the trading window for insiders under SEBI (Prohibition of Insider Trading) Regulations, 2015. It informs about the restriction period for trading in the company's securities by designated persons and their relatives. This is a regulatory compliance announcement related to insider trading restrictions, not a financial report, management change, or other specific filings. The document is short and serves as an official regulatory announcement. Therefore, it fits best under Regulatory Filings (RNS).
2023-11-08 English
Copy of Newspaper Publication
Regulatory Filings
2023-11-04 English
Investor Presentation
Investor Presentation Classification · 100% confidence The document is an investor presentation dated November 2, 2023, for the quarter ended September 30, 2023 (Q2 FY2024). It includes detailed company overview, management team information, quarterly financial performance data including revenue, EBITDA, PAT, and management commentary. The document is lengthy (15,000 characters) and contains substantive financial data and analysis, not just an announcement or summary. It is explicitly titled as an "Investor Presentation" and contains slides and detailed financial and strategic information aimed at investors. Therefore, it fits the category of an Investor Presentation (IP).
2023-11-02 English
Press Release
Earnings Release Classification · 95% confidence The document is a press release announcing the financial results for the quarter ended September 30, 2023. It includes key financial metrics such as revenues, EBITDA, and PAT for the quarter and half-year periods, along with commentary from the Managing Director. The document is relatively short (3764 characters) and is titled as a 'Press Release' rather than a full financial report. It does not contain detailed financial statements or comprehensive analysis typical of an Interim/Quarterly Report (IR). Therefore, it fits the definition of an Earnings Release (ER), which is the initial announcement of quarterly financial results with key highlights only. Q2 2024
2023-11-02 English
Financial Result Updates
Interim / Quarterly Report Classification · 95% confidence The document is a detailed announcement from Heranba Industries Limited dated November 2, 2023, regarding the outcome of a Board Meeting. It specifically mentions the approval of unaudited financial results for the quarter ended September 30, 2023, along with the auditor's limited review report. The document includes detailed financial statements such as the standalone assets and liabilities as of September 30, 2023, and references compliance with SEBI Listing Regulations. The presence of unaudited quarterly financial results and auditor's review report indicates this is an Interim / Quarterly Report. The document length (15,000 characters) and the inclusion of substantive financial data confirm it is the report itself, not just an announcement or certification. Therefore, the appropriate classification is Interim / Quarterly Report (IR).
2023-11-02 English

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.